|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Noordhuis MG, Fehrmann RS, Wisman GB,
Nijhuis ER, van Zanden JJ, Moerland PD, Ver Loren van Themaat E,
Volders HH, Kok M, ten Hoor KA, et al: Involvement of the TGF-beta
and beta-catenin pathways in pelvic lymph node metastasis in
early-stage cervical cancer. Clin Cancer Res. 17:1317–1330. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang L, Jia X, Li N, Chen C, Liu Y and
Wang H: Comprehensive clinic-pathological characteristics of
cervical cancer in southwestern China and the clinical significance
of histological type and lymph node metastases in young patients.
PLoS One. 8:e758492013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gambus A, Jones RC, Sanchez-Diaz A,
Kanemaki M, van Deursen F, Edmondson RD and Labib K: GINS maintains
association of Cdc45 with MCM in replisome progression complexes at
eukaryotic DNA replication forks. Nat Cell Biol. 8:358–366. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rantala JK, Edgren H, Lehtinen L, Wolf M,
Kleivi K, Vollan HK, Aaltola AR, Laasola P, Kilpinen S, Saviranta
P, et al: Integrative functional genomics analysis of sustained
polyploidy phenotypes in breast cancer cells identifies an
oncogenic profile for GINS2. Neoplasia. 12:877–888. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu M, Pan H, Zhang F, Zhang Y, Zhang Y,
Xia H, Zhu J, Fu W and Zhang X: Identification of TNM
stage-specific genes in lung adenocarcinoma by genome-wide
expression profiling. Oncol Lett. 6:763–768. 2013.PubMed/NCBI
|
|
8
|
Zheng M, Zhou Y, Yang X, Tang J, Wei D,
Zhang Y, Jiang JL, Chen ZN and Zhu P: High GINS2 transcript level
predicts poor prognosis and correlates with high histological grade
and endocrine therapy resistance through mammary cancer stem cells
in breast cancer patients. Breast Cancer Res Treat. 148:423–436.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang X, Zhong L, Liu BZ, Gao YJ, Gao YM
and Hu XX: Effect of GINS2 on proliferation and apoptosis in
leukemic cell line. Int J Med Sci. 10:1795–1804. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Obama K, Ura K, Satoh S, Nakamura Y and
Furukawa Y: Up-regulation of PSF2, a member of the GINS
multiprotein complex, in intrahepatic cholangiocarcinoma. Oncol
Rep. 14:701–706. 2005.PubMed/NCBI
|
|
11
|
Mazurek A, Luo W, Krasnitz A, Hicks J,
Powers RS and Stillman B: DDX5 regulates DNA replication and is
required for cell proliferation in a subset of breast cancer cells.
Cancer Discov. 2:812–825. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Costa A, Hood IV and Berger JM: Mechanisms
for initiating cellular DNA replication. Annu Rev Biochem.
82:25–54. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oehlmann M, Score AJ and Blow JJ: The role
of Cdc6 in ensuring complete genome licensing and S phase
checkpoint activation. J Cell Biol. 165:181–190. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weaver BA and Cleveland DW: Does
aneuploidy cause cancer? Curr Opin Cell Biol. 18:658–667. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dutta A: Chaotic license for genetic
instability and cancer. Nat Genet. 39:10–11. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hermand D and Nurse P: Cdc18 enforces
long-term maintenance of the S phase checkpoint by anchoring the
Rad3-Rad26 complex to chromatin. Mol Cell. 26:553–563. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gan N, Du Y, Zhang W and Zhou J: Increase
of Mcm3 and Mcm4 expression in cervical squamous cell carcinomas.
Eur J Gynaecol Oncol. 31:291–294. 2010.PubMed/NCBI
|
|
18
|
Tane S, Sakai Y, Hokka D, Okuma H, Ogawa
H, Tanaka Y, Uchino K, Nishio W, Yoshimura M and Maniwa Y:
Significant role of Psf3 expression in non-small-cell lung cancer.
Cancer Sci. 106:1625–1634. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Benedet JL, Bender H, Jones H III, Ngan HY
and Pecorelli S: FIGO Committee on Gynecologic Oncology: FIGO
staging classifications and clinical practice guidelines in the
management of gynecologic cancers. Int J Gynaecol Obstet.
70:209–262. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koh WJ, Greer BE, Abu-Rustum NR, Apte SM,
Campos SM, Chan J, Cho KR, Cohn D, Crispens MA, DuPont N, et al:
National Comprehensive Cancer Network: Cervical cancer. J Natl
Compr Canc Netw. 11:320–343. 2013.PubMed/NCBI
|
|
21
|
Selman TJ, Mann C, Zamora J, Appleyard TL
and Khan K: Diagnostic accuracy of tests for lymph node status in
primary cervical cancer: A systematic review and meta-analysis.
CMAJ. 178:855–862. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Matsuura Y, Kawagoe T, Toki N, Tanaka M
and Kashimura M: Long-standing complications after treatment for
cancer of the uterine cervix - clinical significance of medical
examination at 5 years after treatment. Int J Gynecol Cancer.
6:294–297. 2006. View Article : Google Scholar
|
|
23
|
Altgassen C, Hertel H, Brandstädt A,
Köhler C, Dürst M and Schneider A: AGO Study Group: Multicenter
validation study of the sentinel lymph node concept in cervical
cancer: AGO Study Group. J Clin Oncol. 26:2943–2951. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Slama J, Dundr P, Dusek L and Cibula D:
High false negative rate of frozen section examination of sentinel
lymph nodes in patients with cervical cancer. Gynecol Oncol.
129:384–388. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bonfrer JM, Gaarenstroom KN, Korse CM, Van
Bunningen BN and Kenemans P: Cyfra 21–1 in monitoring cervical
cancer: A comparison with tissue polypeptide antigen and squamous
cell carcinoma antigen. Anticancer Res. 17:2329–2334.
1997.PubMed/NCBI
|
|
26
|
Esajas MD, Duk JM, de Bruijn HW, Aalders
JG, Willemse PH, Sluiter W, Pras B, ten Hoor K, Hollema H and van
der Zee AG: Clinical value of routine serum squamous cell carcinoma
antigen in follow-up of patients with early-stage cervical cancer.
J Clin Oncol. 19:3960–3966. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Avall-Lundqvist EH, Sjovall K, Nilsson BR
and Eneroth PH: Prognostic significance of pretreatment serum
levels of squamous cell carcinoma antigen and CA 125 in cervical
carcinoma. Eur J Cancer. 28A:1695–1702. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Duk JM, Groenier KH, de Bruijn HW, Hollema
H, ten Hoor KA, van der Zee AG and Aalders JG: Pretreatment serum
squamous cell carcinoma antigen: A newly identified prognostic
factor in early-stage cervical carcinoma. J Clin Oncol. 14:111–118.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yuan CC, Wang PH, Ng HT, Tsai LC, Juang CM
and Chiu LM: Both TPA and SCC-Ag levels are prognostic even in
high-risk stage Ib-IIa cervical carcinoma as determined by a
stratification analysis. Eur J Gynaecol Oncol. 23:17–20.
2002.PubMed/NCBI
|
|
30
|
Strauss HG, Laban C, Lautenschläger C,
Buchmann J, Schneider I and Koelbl H: SCC antigen in the serum as
an independent prognostic factor in operable squamous cell
carcinoma of the cervix. Eur J Cancer. 38:1987–1991. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Molina R, Filella X, Lejarcegui JA, Pahisa
J, Torné A, Rovirosa A, Mellado B, Ordi J, Puig-Tintore LM,
Alicarte J, et al: Prospective evaluation of squamous cell
carcinoma and carcinoembryonic antigen as prognostic factors in
patients with cervical cancer. Tumour Biol. 24:156–164. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Reesink-Peters N, van der Velden J, Hoor
Ten KA, Boezen HM, de Vries EG, Schilthuis MS, Mourits MJ, Nijman
HW, Aalders JG, Hollema H, et al: Preoperative serum squamous cell
carcinoma antigen levels in clinical decision making for patients
with early-stage cervical cancer. J Clin Oncol. 23:1455–1462. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gaarenstroom KN, Kenter GG, Bonfrer JM,
Korse CM, Van de Vijver MJ, Fleuren GJ and Trimbos JB: Can initial
serum cyfra 21–1, SCC antigen, and TPA levels in squamous cell
cervical cancer predict lymph node metastases or prognosis? Gynecol
Oncol. 77:164–170. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Montag TW: Tumor markers in gynecologic
oncology. Obstet Gynecol Surv. 45:94–105. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Duk JM, de Bruijn HW, Groenier KH, Hollema
H, ten Hoor KA, Krans M and Aalders JG: Cancer of the uterine
cervix: Sensitivity and specificity of serum squamous cell
carcinoma antigen determinations. Gynecol Oncol. 39:186–194. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li J, Chen P, Mao CM, Tang XP and Zhu LR:
Evaluation of diagnostic value of four tumor markers in
bronchoalveolar lavage fluid of peripheral lung cancer. Asia Pac J
Clin Oncol. 10:141–148. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cao X, Zhang L, Feng GR, Yang J, Wang RY,
Li J, Zheng XM and Han YJ: Preoperative Cyfra21-1 and SCC-Ag serum
titers predict survival in patients with stage II esophageal
squamous cell carcinoma. J Transl Med. 10:1972012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Torre GC: SCC antigen in malignant and
nonmalignant squamous lesions. Tumour Biol. 19:517–526. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ryu HK, Baek JS, Kang WD and Kim SM: The
prognostic value of squamous cell carcinoma antigen for predicting
tumor recurrence in cervical squamous cell carcinoma patients.
Obstet Gynecol Sci. 58:368–376. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Moody CA and Laimins LA: Human
papillomavirus oncoproteins: Pathways to transformation. Nat Rev
Cancer. 10:550–560. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ferenczy A and Franco E: Persistent human
papillomavirus infection and cervical neoplasia. Lancet Oncol.
3:11–16. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Schiffman M, Castle PE, Jeronimo J,
Rodriguez AC and Wacholder S: Human papillomavirus and cervical
cancer. Lancet. 370:890–907. 2007. View Article : Google Scholar : PubMed/NCBI
|
